为增强瘤微环境相互作用而设计的蛋白质甘氨酸降解酶在细胞癌中
Lingling Dong1, Xiaoli Zhang2, Xiaopeng Yu3
1Second Department of Cardiovascular Medicine, Shengjing Hospital Affiliated to China Medical University, Shenyang, Liaoning Province, China.
International journal of biological macromolecules
|January 30, 2025
概括
优化的蛋白质甘氨酸降解酶在细胞癌 (RCC) 治疗中表现出增强的稳定性和活性. 这些定制酶有效地分解瘤细胞外基质,提供了一种新的治疗方法.
科学领域:
- 生物化学 生化学
- 酶学 是一种酶学.
- 癌症生物学 癌症生物学
背景情况:
- 细胞癌 (RCC) 在癌症治疗中提出了重大挑战.
- 瘤微环境 (TME),特别是细胞外基质 (ECM),在瘤进展和治疗耐药性方面发挥着至关重要的作用.
- 蛋白质甘氨酸降解酶是瘤ECM准的潜在治疗剂.
研究的目的:
- 通过向性突变发生来优化蛋白质甘氨酸降解酶,以增强与RCC瘤微环境的相互作用.
- 改善这些酶的酶活性,稳定性和结构完整性,用于治疗应用.
主要方法:
- 综合性突变发生方法来识别关键突变.
- 计算方法包括分子对接和蛋白质结构预测 (同质模型,晶体学) 来分析酶活性位点.
- 在体外酶活性和稳定性测试.
- 在RCC模型中评估蛋白质甘氨酸分解.
主要成果:
- 确定了60种关键突变,增强了酶活性,稳定性和结构完整性.
- 与野生类型 (WT) 酶相比,氨酸酶的特异活性增加了35%,Km值下降.
- 修改后的酶保持了85%的活性,并显示出更好的热稳定性,在体外显著减少蛋白质甘油的分解 (70%).
- 计算模型预测了酶-ECM相互作用的改善.
结论:
- 有针对性的突变发生成功优化了蛋白质甘氨酸降解酶,以提高RCC治疗的疗效.
- 这些定制酶通过向瘤ECM,代表了针对RCC的新,更稳定,更有效的治疗策略.
- 这些发现支持这些修饰酶在定制癌症治疗中的潜力.
关键词:
CD8+ T细胞透 CD8+ T细胞透优化酶的优化 酶的优化细胞外矩阵 (ECM) 降解降解蛋白质甘氨酸降解酶 蛋白质甘氨酸降解酶细胞癌 (RCC) 是一种细胞癌.有针对性的突变发生.治疗性酶是一种治疗性酶.瘤微环境 (TME) 是指瘤的微环境.更多相关视频
12:22The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
33.5K
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
13.5K
相关概念视频
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K